Cemex, S.A.B. de C.V. Sponsored ADR (CX)

Total Assets

$28.27B

Quarterly · Period ending: · USD

CX logo

CX Total Assets

Latest reported$28.27B
CX Quarterly Total Assets ($11.02B → $28.27B)
High-resolution chart · PNG

CX total assets history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Cemex, S.A.B. de C.V. Sponsored ADR Total Assets — Quarterly (USD)
Period endingTotal Assets (USD)
28,269,103,000
28,100,128,000
28,966,084,227
29,008,753,664
28,801,933,000
27,974,844,000
27,299,000,000
27,994,794,000
28,035,163,000
28,602,557,000
29,601,000,000
27,658,616,000
27,961,649,000
27,488,330,000
27,491,000,000
26,603,032,000
26,986,757,000
27,696,000,000
26,780,307,000
27,909,863,000
27,562,368,000
27,425,000,000
29,233,043,000
29,959,819,000
28,597,945,000
29,363,000,000
28,508,654,000
28,970,212,000
28,900,275,000
29,181,000,000
28,689,095,658
28,974,795,161
29,199,009,340
29,009,276,532
29,340,871,566
29,448,072,155
28,972,471,600
29,110,889,983
30,426,515,100
30,745,489,891
32,224,868,229
31,399,625,704
32,946,334,792
33,995,592,942
34,443,684,762
34,954,887,810
36,984,158,365
37,712,408,020
37,881,692,342
38,083,840,792
37,002,521,535
36,549,645,390
37,324,580,266
37,295,225,631
39,055,102,437
38,348,779,566
39,681,969,134
38,905,353,282
39,901,490,961
42,418,729,250
42,712,555,714
41,770,492,069
43,652,453,549
42,871,445,741
45,013,923,741
44,503,668,602
45,513,922,275
45,453,891,190
44,177,069,224
45,334,544,925
49,517,345,592
51,914,907,000
51,061,757,000
49,662,000,000
48,713,344,000
44,216,977,000
29,728,390,000
29,972,000,000
27,879,817,000
27,817,159,000
27,248,950,000
26,796,000,000
25,282,248,000
26,267,538,000
26,470,681,000
17,377,655,000
16,767,007,000
16,767,007,000
16,457,797,000
16,034,330,000
16,201,051,000
16,700,910,000
15,891,582,000
15,922,221,000
16,290,214,000
16,138,929,000
16,628,559,000
16,252,312,000
16,146,979,000
16,536,155,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.